US Patent 11351246 Recombinant measles vaccine expressing hTERT
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Elodie Pliquet0
Frédéric Tangy0
Pierre Langlade Demoyen0
Edits on 29 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 24 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 22 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+404 characters)
US Patent 11351246 Recombinant measles vaccine expressing hTERT
Article
The invention relates a recombinant measles virus plasmid capable of expressing a human telomerase reverse transcriptase (hTERT) protein fused at N-terminus with a protein enhancing addressing of the hTERT protein to proteasome. The invention further relates to a vaccine comprising said plasmid or particles rescued therefrom, and uses thereof, especially in preventing or treating a tumor in a patient.
Infobox
Is a
Patent jurisdiction
Patent number
11351246
Date of patent
June 7, 2022
Patent application number
16611786
Date Filed
May 7, 2018
Patent citations
Patent primary examiner
Find more entities like US Patent 11351246 Recombinant measles vaccine expressing hTERT
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
